TWST analyst estimates
Twist Bioscience (TWST) analyst ratings, the average price target and its range, and every firm's latest call.
- 8 firms rate TWST: 7 buy, 0 hold, 1 sell.
- The average price target is $144.91 from None analysts, from $89.00 to $215.00.
TWST analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Nov 13, 2026 | Canaccord Genuity | Twist Bioscience (TWST) PT Lowered to $150 at Canaccord | $150.00 |
| Nov 13, 2026 | RBC Capital | Twist Bioscience (TWST) PT Lowered to $137 at TD Cowen | $137.00 |
| Nov 12, 2026 | Jefferies | Twist Bioscience (TWST) PT Lowered to $125 at Jefferies | $125.00 |
| Oct 12, 2026 | Canaccord Genuity | Twist Bioscience price target raised to $205 from $120 at Canaccord | $205.00 |
| Oct 8, 2026 | Jefferies | Jefferies Starts Twist Bioscience (TWST) at Hold | $150.00 |
| Oct 7, 2026 | Barclays | Twist Bioscience price target raised to $215 from $112 at Barclays | $215.00 |
| Oct 1, 2026 | Guggenheim | Twist Bioscience price target raised to $212 from $107 at Guggenheim | $212.00 |
| Sep 29, 2026 | Leerink Partners | Twist Bioscience price target raised to $190 from $160 at Leerink | $190.00 |
| Sep 17, 2026 | Leerink Partners | Twist Bioscience price target raised to $160 from $120 at Leerink | $160.00 |
| Sep 9, 2026 | UBS | Twist Bioscience initiated with a Neutral at UBS | $144.00 |
| Aug 5, 2026 | Piper Sandler | Twist Bioscience price target raised to $115 from $85 at Piper Sandler | $115.00 |
| Aug 4, 2026 | Robert W. Baird | Twist Bioscience price target raised to $115 from $113 at Baird | $115.00 |
| Jul 16, 2026 | Leerink Partners | Twist Bioscience price target raised to $110 from $80 at Leerink | $110.00 |
| Jul 14, 2026 | Canaccord Genuity | Twist Bioscience price target raised to $120 from $90 at Canaccord | $120.00 |
| Jul 6, 2026 | Evercore ISI | Twist Bioscience downgraded to In Line from Outperform at Evercore ISI | $102.00 |